Bicocca Open Archive

Logo unimib boa
FAVERIO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.465
EU - Europa 3.615
AS - Asia 1.452
SA - Sud America 18
OC - Oceania 12
AF - Africa 8
Totale 12.570
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.398
IT - Italia 983
DE - Germania 740
SE - Svezia 555
SG - Singapore 506
CN - Cina 491
IE - Irlanda 472
RU - Federazione Russa 290
HK - Hong Kong 188
GB - Regno Unito 156
UA - Ucraina 91
CA - Canada 65
VN - Vietnam 65
FI - Finlandia 64
AT - Austria 61
IN - India 61
FR - Francia 52
ID - Indonesia 51
DK - Danimarca 40
BE - Belgio 32
TR - Turchia 26
CZ - Repubblica Ceca 22
NL - Olanda 22
JP - Giappone 16
IR - Iran 9
AU - Australia 8
PK - Pakistan 8
CL - Cile 7
MN - Mongolia 7
KR - Corea 6
RO - Romania 6
CH - Svizzera 5
BR - Brasile 4
ES - Italia 4
GR - Grecia 4
NZ - Nuova Zelanda 4
SC - Seychelles 4
BD - Bangladesh 3
BG - Bulgaria 3
EG - Egitto 3
IL - Israele 3
PE - Perù 3
PH - Filippine 3
PL - Polonia 3
AR - Argentina 2
CO - Colombia 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 12.570
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.176
Fairfield 687
Chandler 678
Frankfurt am Main 576
Dublin 458
Singapore 424
Wilmington 414
Ashburn 388
Houston 339
Woodbridge 307
Milan 267
Seattle 254
New York 230
Cambridge 203
Hong Kong 188
Princeton 172
Dearborn 155
Shanghai 98
Altamura 85
Santa Clara 84
Lawrence 80
Nanjing 79
Jacksonville 78
Fremont 58
Vienna 57
Beijing 54
Boardman 51
Helsinki 50
Jakarta 48
San Diego 46
Chicago 45
Guangzhou 45
London 39
Dong Ket 35
Rome 31
Brussels 30
Toronto 28
Lissone 24
Monza 24
Andover 23
Jinan 23
Nanchang 22
Brno 20
Hangzhou 19
Falls Church 15
Jiaxing 14
Shenyang 14
Genoa 13
Hebei 13
Ningbo 13
Tianjin 13
Pune 12
Ottawa 11
Bologna 10
Kocaeli 9
Los Angeles 9
Norwalk 9
Washington 9
Zhengzhou 9
Brescia 8
Changsha 8
Dallas 8
Groningen 8
Munich 8
Palermo 8
Turin 8
Carate Brianza 7
Edmonton 7
Hefei 7
Lachine 7
Leawood 7
Moscow 7
Amsterdam 6
Kunming 6
Paris 6
Taizhou 6
Atlanta 5
Desio 5
Faisalabad 5
Kiev 5
Lappeenranta 5
Marietta 5
Reggio Nell'emilia 5
Rovereto 5
San Mateo 5
Tappahannock 5
Upper Marlboro 5
Vigevano 5
Auckland 4
Bonndorf 4
Castrolibero 4
Cincinnati 4
Cologne 4
Columbus 4
Florence 4
Naples 4
Nürnberg 4
Padova 4
Sacramento 4
San Francisco 4
Totale 9.595
Salva come PNG Salva come JPEG
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 331
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 308
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 294
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 282
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 282
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 280
Early referral to palliative care services in patients with IPF: A tool to take a step forward 270
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 251
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 229
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 219
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 214
Impact of traffic-related air pollution on pulmonary oxidative stress 197
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 189
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 184
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 183
Janus-faced amiodarone-induced pneumopathy 183
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 181
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 181
A 61-year-old female with chronic cough and purulent sputum 174
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 170
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 165
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 165
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians 165
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 163
A second update on mapping the human genetic architecture of COVID-19 159
Hospital admission decision for patients with community-acquired pneumonia 155
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 155
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 154
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 153
Clinical differences in sarcoidosis patients with and without lymphoma: A single-centre retrospective cohort analysis 152
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 152
Mapping the human genetic architecture of COVID-19 151
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 150
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 148
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 142
Long-term prognosis in community-acquired pneumonia 141
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 139
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 136
The management of community-acquired pneumonia in the elderly 135
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 135
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 132
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 130
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 128
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 128
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 126
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 126
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 125
Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan 121
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 120
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 119
History of lung volume reduction procedures 119
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 118
Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update 116
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients 115
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 113
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 113
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 113
Individualizing duration of antibiotic therapy in community-acquired pneumonia 111
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 110
Non-antibiotic therapies for CAP 107
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study 103
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 103
New biomarkers in community-acquired pneumonia: Another step in improving outcome prediction 101
Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function 99
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancements 97
Long-term macrolides in diffuse interstitial lung diseases 96
Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders 96
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 96
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 95
European Respiratory Society International Congress 2017: highlights from the Clinical Assembly 94
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 90
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 87
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 86
COVID-19. The Pulmonologist and the new scenarios on a new pandemic 86
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 84
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 81
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 81
Utility and safety of bronchoscopy during the SARS-CoV-2 outbreak in Italy: A retrospective, multicentre study 80
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 78
Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia 76
How to choose the duration of antibiotic therapy in patients with pneumonia 75
Early outcomes in CAP: Clinical stability, clinical failure and nonresolving pneumonia 75
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 74
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 70
Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions 69
Interstitial pneumonia associated with autoimmune diseases: a possible mimicker of SARS-CoV-2 pneumonia 69
Differences of Acute Exacerbations in Idiopathic Pulmonary Fibrosis compared to otherfibrotic lung diseases 67
Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association 65
Re: Selective digestive decontamination saves lives whilst preventing resistance 64
RA-ILD: does more detailed radiological classification add something to our knowledge of this condition? 63
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 58
Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management 57
Interstitial lung disease in ANCA-associated vasculitis: another step forward 55
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 50
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 46
Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population 39
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 36
Diagnostic delay in bronchiectasis: an Italian perspective 35
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment 32
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres 31
Totale 12.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.556 0 0 95 146 132 220 199 184 176 192 111 101
2020/20212.900 120 131 270 268 311 309 298 358 229 226 172 208
2021/20221.818 192 193 230 174 100 159 75 122 74 98 134 267
2022/20232.624 278 694 307 232 191 386 41 173 166 26 77 53
2023/20241.923 46 73 121 98 235 447 330 96 117 52 39 269
2024/20251.055 297 554 204 0 0 0 0 0 0 0 0 0
Totale 13.168